SAN DIEGO, Feb. 17 /PRNewswire/ -- Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has successfully met Drug Enforcement Agency (DEA) requirements to be registered for the development and manufacture of Schedule IV and V controlled substances.
Controlled substances are designated as Schedule I-V according to their medical use, potential for abuse and safety or dependence liability. In order to research, manufacture or distribute a controlled substance, a person or entity must be audited and registered by the DEA.
About Pharmatek Laboratories, Inc.
Pharmatek Laboratories Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, and cytotoxic and high-potency development.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Timothy M. Scott
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=50335
Jeffrey A. Bibbs
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=48157
CONTACT: Ryan Lane, Marketing Coordinator of Pharmatek Laboratories, Inc.,
+1-858-805-6383 x284, rlane@pharmatek.com
Web site: http://www.pharmatek.com/
